Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene.

MLA

Kostrzewska-Poczekaj, Magdalena, et al. “Recurrent Amplification in the 22q11 Region in Laryngeal Squamous Cell Carcinoma Results in Overexpression of the CRKL but Not the MAPK1 Oncogene.” Cancer Biomarkers, vol. 8, no. 1, Sept. 2011, pp. 11–19. EBSCOhost, https://doi.org/10.3233/DMA-2011-0814.

APA

Kostrzewska-Poczekaj, M., Giefing, M., Jarmuz, M., Brauze, D., Pelinska, K., Grenman, R., Bartochowska, A., Szyfter, W., & Szyfter, K. (2011). Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. Cancer Biomarkers, 8(1), 11–19. https://doi.org/10.3233/DMA-2011-0814

Chicago

Kostrzewska-Poczekaj, Magdalena, Maciej Giefing, Malgorzata Jarmuz, Damian Brauze, Kinga Pelinska, Reidar Grenman, Anna Bartochowska, Witold Szyfter, and Krzysztof Szyfter. 2011. “Recurrent Amplification in the 22q11 Region in Laryngeal Squamous Cell Carcinoma Results in Overexpression of the CRKL but Not the MAPK1 Oncogene.” Cancer Biomarkers 8 (1): 11–19. doi:10.3233/DMA-2011-0814.